Skip to content

FP7H2020HORIZON

Miltenyi Biotec GmbH

Country
DEGermany
Defence projects
0
Projects, all programmes
34
As coordinator
0
EU contribution (CORDIS)
EUR 9,044,883
Active
2008 to 2024

Projects

34 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
PlasmACTPlasma Medicine against Actinic KeratosisHORIZON2024Associated partnerEUR 0
GET-INThe GEne Therapy INnovation Training NetworkHORIZON2023Associated partnerEUR 0
HUGODECAHuman Gonad Developmental Cell AtlasH20202020ParticipantEUR 0
ENDONANOQuantitative detection of bacterial endotoxin by novel nanotechnological approachesH20202019ParticipantEUR 0
RESTORERESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For PatientsH20202019ParticipantEUR 8,750
TRAIN-HEARTTRAIN-HEARTH20202019ParticipantEUR 252,788
MATURE-NKMAnufacturing of TUmour-REactive Natural Killer cellsH20202018ParticipantEUR 62,304
EUROoCInterdisciplinary training network for advancing Organ-on-a-chip technology in EuropeH20202018ParticipantEUR 28,088
TRACETransfer of multivirus-specific T-cells following transplantationH20202018ParticipantEUR 77,653
SCIDNETDevelopIng Genetic medicines for Severe Combined Immunodeficiency (SCID)H20202016ParticipantEUR 296,200
CARATChimeric Antigen Receptors (CARs) for Advanced TherapiesH20202016ParticipantEUR 1,178,825
PIX4LIFESilicon Nitride Photonic Integrated Circuit Pilot line for Life Science Applications in the Visible RangeH20202016ParticipantEUR 54,071
PROCROPProfessional cross-priming for ovary and prostate cancerH20202015ParticipantEUR 1,345,000
HumEnUpscaling human insulin-producing beta cell production by efficient differentiation and expansion of endoderm progenitorsFP72014ParticipantEUR 205,486
NEUROKINEInitial Training Network for Neurogical disorders orchestrated by cytoKinesFP72013ParticipantEUR 146,951
PLOIDYNETThe impact of chromosomal instability on health: Molecular causes and consequences of aneuploidyFP72013ParticipantEUR 205,555
NEUROSTEMCELLREPAIREuropean stem cell consortium for neural cell replacement, reprogramming and functional brain repairFP72013ParticipantEUR 410,500
CELLEUROPEImproving HSCT By Validation Of Biomarkers & Development Of Novel Cellular TherapiesFP72012ParticipantEUR 190,801
NATURIMMUNNatural Killer Cell-Based Anti-Cancer Immunotherapies: Research training in molecular medicine and biotechnology businessFP72012ParticipantEUR 222,069
MARRIAGEMARie CuRIe AGEing NetworkFP72012ParticipantEUR 199,051

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.